Embedded Files
Drug Substance Analysis
Drug Substance Analysis
In my role at the United States Pharmacopeia, I develop and validate analytical methods to analyze active/key pharmaceutical ingredients and their organic and inorganic impurities. These methods enable quantification of the APIs, identification of process impurities and degradation products as well as their quantification, which are then used to test and assess pharmaceutical raw materials as well as finished pharmaceutical products.
Drug Formulation/Product Analysis
Drug Formulation/Product Analysis
My drug formulation development experience started during my MS in Pharmaceutics program back in 2012, where I was trained to develop and characterize microspheres. Although I do not work on drug formulation development anymore, I started using my analytical chemistry skills to collaborate with several formulation labs to study different pharmacokinetic behaviors, specially drug targeting, release, uptake, stability and solubility of various drug delivery systems.
Sodium acetate mediated crystalline solid dispersion of docetaxel.
(Ref.: Ngo et al. IJP 2018)
Microbicide targeting HIV-1 gp-120.
(Ref.: Coulibaly et al. Mol Pharm 2017)
Ionic salt of etoposide-arginine.
(Ref.: Alsalhi et al. ASSAY 2021)
Native and nanomicellar forumlation of etopisde.
(Ref.: Alsalhi et al. ASSAY 2021)
Microsphere encapsulated with Metformin.
(Ref.: Hasan et al. DUJPS 2013)
Microsphere encapsulated with Naproxen.
(Ref.: Akhter et al. DUJPS 2013)
Microsphere encapsulated with Gliclazide.
(Ref.: Ayon et al. DUJPS 2014)
Page updated
Google Sites
Report abuse